28486810|t|A Facile Strategy to Prepare an Enzyme - Responsive Mussel Mimetic Coating for Drug Delivery Based on Mesoporous Silica Nanoparticles
28486810|a|Surface functional mesoporous silica nanoparticles (MSNs) have been widely used as promosing materials for drug delivery. Herein, we reported a facile strategy to construct MSNs coated by enzyme - resposive polylysine - dopamine (PLDA) films through self-polymerization of dopamine derivative lysine - dopamine, in which the drug could be loaded and delivered efficiently. In detail, RhB or DOX was used as a drug model and loaded in functional MSNs via a one-pot procedure among MSNs, drug, and lysine - dopamine (LDA) under basic conditions. Owing to the fact that the peptide bonds between lysine and dopamine can be cleaved under triggering by pepsin, the resulting RhB / DOX @ PLDA - MSNs exibit enzyme - responsive characterization. After the DOX @ PLDA - MSNs enter into the cancer cells, the drug can be released effectively through degradation of peptide bonds under the influence of enzyme in cancer cells, which shows marked anticancer activity in vitro. This facile strategy may provide a new platform to construct enzyme - responsive controlled drug delivery systems.
28486810	2	8	Facile	T080	C0205352
28486810	9	17	Strategy	T062	C0035171
28486810	32	38	Enzyme	T116,T126	C0014442
28486810	41	51	Responsive	T169	C0205342
28486810	52	58	Mussel	T204	C0026871
28486810	59	66	Mimetic	T091	C0920591
28486810	67	74	Coating	T080	C1522408
28486810	79	92	Drug Delivery	T058	C1881966
28486810	102	119	Mesoporous Silica	T122,T197	C0037098
28486810	120	133	Nanoparticles	T073	C1450054
28486810	134	141	Surface	T082	C0205148
28486810	142	152	functional	T169	C0205245
28486810	153	170	mesoporous silica	T122,T197	C0037098
28486810	171	184	nanoparticles	T073	C1450054
28486810	186	190	MSNs	T122,T197	C0037098
28486810	227	236	materials	T122	C0005479
28486810	241	254	drug delivery	T058	C1881966
28486810	278	284	facile	T080	C0205352
28486810	285	293	strategy	T062	C0035171
28486810	307	311	MSNs	T122,T197	C0037098
28486810	312	318	coated	T080	C1522408
28486810	322	328	enzyme	T116,T126	C0014442
28486810	331	340	resposive	T169	C0205342
28486810	341	351	polylysine	T116	C0032518
28486810	354	362	dopamine	T109,T121,T123	C0013030
28486810	364	368	PLDA	T109,T121,T123	C0013030
28486810	370	375	films	T167	C1561572
28486810	384	403	self-polymerization	T067	C0314672
28486810	407	415	dopamine	T109,T121,T123	C0013030
28486810	427	433	lysine	T116,T121,T123	C0024337
28486810	436	444	dopamine	T109,T121,T123	C0013030
28486810	459	463	drug	T121	C0013227
28486810	473	479	loaded	T052	C1708715
28486810	484	493	delivered	T169	C1705822
28486810	494	505	efficiently	T080	C0442799
28486810	518	521	RhB	T109,T130	C0073194
28486810	525	528	DOX	T109,T195	C0013089
28486810	543	547	drug	T121	C1254351
28486810	548	553	model	T062	C1515654
28486810	558	564	loaded	T052	C1708715
28486810	568	578	functional	T169	C0205245
28486810	579	583	MSNs	T122,T197	C0037098
28486810	614	618	MSNs	T122,T197	C0037098
28486810	620	624	drug	T121	C1254351
28486810	630	636	lysine	T116,T121,T123	C0024337
28486810	639	647	dopamine	T109,T121,T123	C0013030
28486810	649	652	LDA	T109,T121,T123	C0013030
28486810	660	665	basic	T120	C0178499
28486810	666	676	conditions	T080	C0348080
28486810	705	718	peptide bonds	UnknownType	C0678595
28486810	727	733	lysine	T116,T121,T123	C0024337
28486810	738	746	dopamine	T109,T121,T123	C0013030
28486810	754	761	cleaved	T067	C0596311
28486810	768	781	triggering by	T080	C1444748
28486810	782	788	pepsin	T116,T121,T126	C0030909
28486810	804	807	RhB	T109,T130	C0073194
28486810	810	813	DOX	T109,T195	C0013089
28486810	816	820	PLDA	T109,T121,T123	C0013030
28486810	823	827	MSNs	T122,T197	C0037098
28486810	835	841	enzyme	T116,T126	C0014442
28486810	844	854	responsive	T169	C0205342
28486810	855	871	characterization	T052	C1880022
28486810	883	886	DOX	T109,T195	C0013089
28486810	889	893	PLDA	T109,T121,T123	C0013030
28486810	896	900	MSNs	T122,T197	C0037098
28486810	916	928	cancer cells	T025	C0334227
28486810	934	938	drug	T121	C1254351
28486810	946	954	released	T169	C0391871
28486810	955	966	effectively	T080	C1280519
28486810	975	1003	degradation of peptide bonds	T044	C0597304
28486810	1014	1023	influence	T077	C4054723
28486810	1027	1033	enzyme	T116,T126	C0014442
28486810	1037	1049	cancer cells	T025	C0334227
28486810	1070	1080	anticancer	T109,T121	C0003392
28486810	1081	1089	activity	T169	C0205177
28486810	1090	1098	in vitro	T080	C1533691
28486810	1105	1111	facile	T080	C0205352
28486810	1112	1120	strategy	T062	C0035171
28486810	1161	1167	enzyme	T116,T126	C0014442
28486810	1170	1180	responsive	T169	C0205342
28486810	1181	1191	controlled	T169	C2587213
28486810	1192	1213	drug delivery systems	T058	C1881966